Extraction form for project: Management and Outcomes of Binge-Eating Disorder (BED)

Arms

N/A

Arm Details

1. RefID
2. First author's last name
3. Define groups
4. Group sample sizes
5. Co-Interventions
6. Group 1: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy:Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe tx regimen and any changes in tx during the study period
7. Group 2: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy: Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe tx regimen and any changes in tx during the study period
8. Group 3: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy: Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe tx regimen and any changes in tx during the study period
9. Group 4: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy: Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe tx regimen and any changes in tx during the study period
10. Fidelity of the Intervention
11. Intervention Comments
12. RefID
13. First author's last name
14. Co-Interventions
15. Group 1: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy:Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe treatment regimen and any changes in tx during the study period
16. Group 2: Pharmacotherapy: drug and total daily dose &/or Psychotherapy or Behavioral Therapy: Type, duration and number of treatments &/or CAM: dose/frequency as applicable Describe treatment regimen and any changes in tx during the study period
17. Fidelity of the Intervention
18. Intervention Comments
19. Define groups
20. Group sample sizes
21. RefID
22. First author's last name
23. Define groups
24. Group sample sizes
25. Co-Interventions
26. Group 1
27. Group 2
28. Group 3

Outcomes

N/A

Design

1. RefID
2. First author's last name
3. Trial or study name
4. Research Objective
5. Study design
6. If trial, report blinding
7. Enrollment Period
8. Study Duration, in weeks or months
9. Country
10. Number of sites
11. Location of sites (cities)
12. Type of setting
13. Funding source
14. Study Characteristics Comments
15. RefID
16. First author's last name
17. Research Objective
18. Study design
19. If trial, report blinding
20. Enrollment Period
21. Study Duration, in weeks or months
22. Country
23. Number of sites
24. Location of sites (cities)
25. Type of setting
26. Funding source
27. Study Characteristics Comments
28. RefID
29. First author's last name
30. Research Objective
31. Study design
32. Blinding
33. Enrollment Period
34. Study Duration, in weeks or months
35. Country
36. Number of sites
37. Location of sites (cities)
38. Type of setting
39. Funding source
40. Study Characteristics Comments

Outcome Details

1. RefID
2. First author's last name
3. Outcome collection and measurement: State how outcomes were obtained if not obvious, such as through logs or other self-report tools. State when measurements were obtained, include if data collection was at more than one time point (e.g., end of tx, 3-months following tx). In reporting specific outcomes, clearly state when measured if data was collected at more than one point in time.
4. Binges Outcomes
5. Eating Related Psychopathology Outcomes
6. Psychopathology Outcomes
7. Weight Related Outcomes
8. Biomarker outcomes other than weight Outcomes
9. Quality of Life Outcomes
10. Functional capacity Outcomes
11. subpopulation Outcomes for Eating Related Measure(s)
12. subpopulation Outcomes for eating-related measures continued
13. subpopulation Outcomes for Psychological/Psychiatric Measure(s)
14. subpopulation Outcomes for weight related measure(s)
15. subpopulation Outcomes for biomarker outcomes other than weight
16. Other Outcomes
17. Describe subpopulation
18. subpopulation Outcomes eating-related measures
19. subpopulation Quality of life
20. subpopulation Functional capacity
21. RefID
22. First author's last name
23. Outcome collection and measurement: State how outcomes were obtained if not obvious, such as through logs or other self-report tools. State when measurements were obtained, include if data collection was at more than one time point (e.g., end of tx, 3-months following tx). In reporting specific outcomes, clearly state when measured if data was collected at more than one point in time.
24. Binges Outcomes
25. Eating Related Psychopathology Outcomes
26. Eating Related Psychopathology Outcomes Continued
27. Psychopathology Outcomes
28. Psychopathology Outcomes Continued
29. Weight Related Outcomes
30. Other Outcomes
31. Describe subpopulation
32. subpopulation Definition of Eating Related Measure(s)
33. subpopulation Outcomes
34. RefID
35. First author's last name
36. Outcome collection and measurement
37. Binges Outcomes
38. Eating Related Psychopathology Outcomes
39. Psychopathology Outcomes
40. Weight Related Outcomes
41. Other Outcomes

Baselines

1. RefID
2. First author's last name
3. Overall sample size
4. BED or LOC inclusion definition
5. Other inclusion criteria (in addition to BED or LOC eating criteria)
6. Exclusion criteria
7. Brief summary of population
8. Mean age (Range)
9. % female
10. % non-white
11. Weight
12. Current Major Depressive Disorder: % of Group or Mean (SD) baseline depression score
13. Other relevant characteristics
14. Subgroup analysis?
15. Population Comments
16. Definition of Binges (days; frequency; remission; abstinence etc.)
17. Binges Baseline
18. Definition of Eating Related Psychopathology (EDE; TFEQ; BES; EDI etc.)
19. Eating Related Psychopathology Baseline
20. Definition of Psychopathology (BDI; STAI; BAI; RSE; BSQ)
21. Psychopathology Baseline
22. Definition of weight related measure(s
23. Weight Related Baseline
24. Definition of biomarker outcomes other than weight
25. Biomarker outcomes other than weight Baseline
26. Definition of quality of life
27. Quality of Life Baseline
28. Definition of Functional capacity
29. Functional capacity Baseline
30. Describe subpopulation
31. subpopulation Definition of Eating Related Measure(s)
32. subpopulation Definition of Psychological/Psychiatric Measure(s)
33. subpopulation Definition of weight related measure(s)
34. subpopulation Definition of biomarker outcomes other than weight
35. subpopulation Quality of life
36. subpopulation Functional capacity
37. Definition of Other
38. Other Baseline
39. RefID
40. First author's last name
41. Overall sample size
42. BED or LOC inclusion definition
43. Other inclusion criteria (in addition to BED or LOC eating criteria)
44. Exclusion criteria
45. Brief summary of population
46. Mean age (Range)
47. % female
48. % non-white
49. Weight
50. Current Major Depressive Disorder: % of Group or Mean (SD) baseline depression score
51. Other relevant characteristics
52. Subgroup analysis?
53. Population Comments
54. Definition of Binges (days; frequency; remission; abstinence etc.)
55. Binges Baseline
56. Definition of Eating Related Psychopathology (EDE; TFEQ; BES; EDI etc.)
57. Eating Related Psychopathology Baseline
58. Definition of Psychopathology (BDI; STAI; BAI; RSE; BSQ)
59. Psychopathology Baseline
60. Definition of weight related measure(s
61. Weight Related Baseline
62. Definition of Other Outcomes
63. Other Baseline
64. RefID
65. First author's last name
66. Overall sample size
67. BED or LOC inclusion definition
68. Other inclusion criteria (in addition to BED or LOC eating criteria)
69. Exclusion criteria
70. Brief summary of population
71. Mean age (Range)
72. % female
73. % non-white
74. Weight
75. Current Depression or Depressive Disorder: % of Group or Mean (SD) baseline depression score
76. Other relevant characteristics
77. Subgroup analysis?
78. Population Comments
79. Definition of Binges (days; frequency; remission; abstinence etc.)
80. Binges Baseline
81. Definition of Eating Related Psychopathology (EDE; TFEQ; BES; EDI etc.)
82. Eating Related Psychopathology Baseline
83. Definition of Psychopathology (BDI; STAI; BAI; RSE; BSQ)
84. Psychopathology Baseline
85. Definition of weight related measure(s
86. Weight Related Baseline
87. Definition of Other Outcomes
88. Other Baseline

Results

N/A

Quality

1. Adjust Quality Rating (for Key Questions: 1, 2, 3)
Quality Guideline Used:
Select Current Overall Rating:
Notes on this Rating:
2. Adjust Quality Rating (for Key Questions: 11, 13)
Quality Guideline Used:
Select Current Overall Rating:
Notes on this Rating:
3. Adjust Quality Rating (for Key Questions: 4, 5, 9, 10, 14, 15)
Quality Guideline Used:
Select Current Overall Rating:
Notes on this Rating: